Current Report Filing (8-k)

Date : 08/07/2019 @ 1:01PM
Source : Edgar (US Regulatory)
Stock : Avalon GloboCare Corporation (AVCO)
Quote : 1.53  -0.09 (-5.56%) @ 11:00PM

Current Report Filing (8-k)

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): August 5, 2019

 

AVALON GLOBOCARE CORP.

(Exact name of registrant as specified in its charter)

 

Delaware   000-55709   47-1685128
(State or Other Jurisdiction of Incorporation)   (Commission File Number)    (IRS Employer Identification Number)

 

4400 Route 9 South, Suite 3100, Freehold, New Jersey 07728

(Address of principal executive offices) (zip code)

 

646-762-4517

(Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of

the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

x Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbols   Name of each exchange on which registered
Common Stock, $0.0001 par value per share   AVCO   The Nasdaq Capital Market

 

 

   

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders

 

Avalon GloboCare Corp. (the "Company") held its Annual Meeting on August 6, 2019. Of the 75,655,639 shares of Common Stock outstanding on June 10, 2019, the record date, 51,951,344 shares were represented at the Annual Meeting, in person or by proxy, constituting a quorum. The proposals considered at the Annual Meeting are described in detail in the Proxy Statement. The proposals described below were voted upon at the Annual Meeting and the number of votes cast with respect to each proposal was as set forth below:

 

(1) Elect nine directors until his successor is duly elected and qualified, or until his earlier death, resignation or removal. The nine directors receiving the highest vote were appointed to the board. The following Directors were elected to the board.

 

    For     Withheld  
Wenzhao “Daniel” Lu     47,313,411       24,849  
David Jin     47,313,709       24,551  
Meng Li     47,313,410       24,850  
Yancen Lu     47,316,109       22,151  
Steven A. Sanders     47,320,126       18,134  
Wilbert J. Tauzin II     47,316,067       22,193  
William B. Stilley, III     47,316,123       22,137  
Tevi Troy     47,317,599       20,661  
Yue “Charles” Li     47,313,344       24,916  

 

(2) Ratify the appointment of RBSM LLP as the Company's independent registered public accounting firm for the year ending December 31, 2019. This matter was determined based on majority of the shares cast.

 

For     Against     Abstain  
  50,924,196       927,478       99,670  

 

(3) Approve the adoption of the 2019 Stock Incentive Plan and the reservation of 5,000,000 shares of common stock thereunder. This matter was determined based on majority of the shares cast.

 

For     Against     Abstain  
  47,298,008       36,226       4,026  

 

 

(4) Approve the compensation of the Company's named executive officers on a non-binding, advisory basis. This matter was determined based on majority of the shares cast.

 

For     Against     Abstain  
  47,297,928       33,745       6,587  

 

(5) Vote, on a non-binding, advisory basis, on the frequency with which stockholders would have an opportunity to hold an advisory vote on the Company’s executive compensation program with the option of selecting a frequency of one, two or three years, or abstaining.

 

One     Two     Three     Abstain  
  632,871       3,416       46,697,873       4,100  

 

 

  1  

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  AVALON GLOBOCARE CORP.
     
Dated: August 7, 2019  By: /s/ Luisa Ingargiola
    Name: Luisa Ingargiola
    Title: Chief Financial Officer
     

 

  2  

 

Avalon GloboCare (NASDAQ:AVCO)
Historical Stock Chart

1 Year : From Feb 2019 to Feb 2020

Click Here for more Avalon GloboCare Charts.

Avalon GloboCare (NASDAQ:AVCO)
Intraday Stock Chart

Today : Monday 24 February 2020

Click Here for more Avalon GloboCare Charts.

Latest AVCO Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.